Login Register Cart 0
Generic placeholder image

Current Neuropharmacology

Editor-in-Chief

ISSN (Print): 1570-159X
ISSN (Online): 1875-6190

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents

Author(s): Rohit Pal, Karanvir Singh, Joyson Paul, Shah Alam Khan, Mohd. Javed Naim and Md. Jawaid Akhtar*

Volume 20, Issue 8, 2022

Published on: 12 April, 2022

Page: [1519 - 1553] Pages: 35

DOI: 10.2174/1570159X19666210803144815

Price: $65

conference banner
Abstract

Epilepsy is a chronic neurological disorder, characterized by the predisposition of unprovoked seizures affecting the neurobiological, psychological, cognitive, economic, and social wellbeing of the patient. As per the 2019 report by World Health Organization, it affects nearly 80% of the population, which comes from middle to low-income countries. It has been suggested that 70% of such cases can be treated effectively if properly diagnosed. It is one of the most common neurological diseases affecting 50 million people globally. Most of the antiepileptic drugs used in clinical practice are only 60-80% effective in controlling the disease. These drugs suffer from serious drawbacks of non-selectivity and toxicity that limit their clinical usefulness. Hence, there is a need to search for safe, potent, and effective anti-epileptic drugs. One of the emerging strategies to discover and develop selective and non-toxic anticonvulsant molecules focuses on the design of non-nitrogen heterocyclic compounds (NNHC). Drugs such as valproic acid, gabapentin, viagabatrin, fluorofelbamate, tiagabine, progabide, pregabalin, gamma amino butyric acid (GABA), etc. do not contain a nitrogen heterocyclic ring but are as effective anticonvulsants as conventional heterocyclic nitrogen compounds. This review covers the various classes of NNHC which have been developed in the recent past as anticonvulsants along with their chemistry, percentage yield, structure-activity relationship and biological activity. The most potent compound in each series has been identified for comparative studies, for further structural modification and to improve the pharmacokinetic profile. Various optimized synthetic pathways and diverse functionalities other than nitrogen-containing rings discussed in the article may help medicinal chemists to design safe and effective anticonvulsant drugs in near future.

Keywords: Non-nitrogen heterocyclics, anticonvulsant, amide, GABA, epilepsy, structure activity relationship, antiepileptic drugs.

« Previous Next »
Graphical Abstract

[1]
Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy
[2]
Shimshoni, J.A.; Bialer, M.; Wlodarczyk, B.; Finnell, R.H.; Yagen, B. Potent anticonvulsant urea derivatives of constitutional isomers of valproic acid. J. Med. Chem., 2007, 50(25), 6419-6427.
[http://dx.doi.org/10.1021/jm7009233] [PMID: 17994680]
[3]
Available from:https://www.healthline.com/health/epilepsy/facts-statistics-infographic
[4]
Eadie, M.J. Shortcomings in the current treatment of epilepsy. Expert Rev. Neurother., 2012, 12(12), 1419-1427.
[http://dx.doi.org/10.1586/ern.12.129] [PMID: 23237349]
[5]
Pavia, M.R.; Lobbestael, S.J.; Taylor, C.P.; Hershenson, F.M.; Miskell, D.L. N-phenyl-N'-pyridinylureas as anticonvulsant agents. J. Med. Chem., 1990, 33(2), 854-861.
[http://dx.doi.org/10.1021/jm00164a061] [PMID: 2299648]
[6]
Mohammadi-Khanaposhtani, M.; Ahangar, N.; Sobhani, S.; Masihi, P.H.; Shakiba, A.; Saeedi, M.; Akbarzadeh, T. Design, synthesis, in vivo, and in silico evaluation of new coumarin-1,2,4-oxadiazole hybrids as anticonvulsant agents. Bioorg. Chem., 2019, 89, 102989.
[http://dx.doi.org/10.1016/j.bioorg.2019.102989] [PMID: 31158578]
[7]
Chimirri, A.; De Sarro, A.; De Sarro, G.; Gitto, R.; Zappalà, M. Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives. Farmaco, 2001, 56(11), 821-826.
[http://dx.doi.org/10.1016/S0014-827X(01)01147-8] [PMID: 11765033]
[8]
Shingalapur, R.V.; Hosamani, K.M.; Keri, R.S.; Hugar, M.H. Derivatives of benzimidazole pharmacophore: Synthesis, anticonvulsant, antidiabetic and DNA cleavage studies. Eur. J. Med. Chem., 2010, 45(5), 1753-1759.
[http://dx.doi.org/10.1016/j.ejmech.2010.01.007] [PMID: 20122763]
[9]
Herbes, S.E.; Southworth, G.; Gehrs, C. Organic contaminants in aqueous coal conversion effluents: Environmental consequences and research priorities; Oak Ridge National Lab: Tenn., USA, 1976.
[10]
Schultz, T.W.; Cajina-Quezada, M.; Dumont, J.N. Structure-toxicity relationships of selected nitrogenous heterocyclic compounds. Arch. Environ. Contam. Toxicol., 1980, 9(5), 591-598.
[http://dx.doi.org/10.1007/BF01056938] [PMID: 6776910]
[11]
Kamiński, K.; Rapacz, A.; Łuszczki, J.J.; Latacz, G.; Obniska, J.; Kieć-Kononowicz, K.; Filipek, B. Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives. Bioorg. Med. Chem., 2015, 23(10), 2548-2561.
[http://dx.doi.org/10.1016/j.bmc.2015.03.038] [PMID: 25868743]
[12]
Tripathi, L.; Singh, R.; Stables, J.P. Design & synthesis of N′-[substituted] pyridine-4-carbohydrazides as potential anticonvulsant agents. Eur. J. Med. Chem., 2011, 46(2), 509-518.
[http://dx.doi.org/10.1016/j.ejmech.2010.11.030] [PMID: 21167624]
[13]
Zayed, M.F. New fluorinated quinazolinone derivatives as anticonvulsant agents. J. Taibah Univ. Med. Sci., 2014, 9(2), 104-109.
[http://dx.doi.org/10.1016/j.jtumed.2013.11.009]
[14]
Grover, G.; Nath, R.; Bhatia, R.; Akhtar, M.J. Synthetic and therapeutic perspectives of nitrogen containing heterocycles as anti-convulsants. Bioorg. Med. Chem., 2020, 28(15), 115585.
[http://dx.doi.org/10.1016/j.bmc.2020.115585] [PMID: 32631563]
[15]
Song, M-X.; Deng, X-Q. Recent developments on triazole nucleus in anticonvulsant compounds: A review. J. Enzyme Inhib. Med. Chem., 2018, 33(1), 453-478.
[http://dx.doi.org/10.1080/14756366.2017.1423068] [PMID: 29383949]
[16]
Sharma, B; Verma, A; Prajapati, S; Sharma, UK Synthetic methods, chemistry, and the anticonvulsant activity of thiadiazoles. Int. J. Med. Chem., 2013, 2013, 348948.
[http://dx.doi.org/10.1155/2013/348948]
[17]
Wei, C-X.; Bian, M.; Gong, G-H. Current research on antiepileptic compounds. Molecules, 2015, 20(11), 20741-20776.
[http://dx.doi.org/10.3390/molecules201119714] [PMID: 26610448]
[18]
Waszkielewicz, A.M.; Gunia-Krzyżak, A.; Powroźnik, B.; Słoczyńska, K.; Pękala, E.; Walczak, M.; Bednarski, M.; Żesławska, E.; Nitek, W.; Marona, H. Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-2-[2-(phenoxy)ethoxy]ethylaminoalkanols as anticonvulsant agents. Bioorg. Med. Chem., 2016, 24(8), 1793-1810.
[http://dx.doi.org/10.1016/j.bmc.2016.03.006] [PMID: 26988801]
[19]
Nikalje, A.P.G.; Shaikh, A.N.; Shaikh, S.I.; Kalam Khan, F.A.; Sangshetti, J.N.; Shinde, D.B. Microwave assisted synthesis and docking study of N-(2-oxo-2-(4-oxo-2-substituted thiazolidin-3ylamino)ethyl)benzamide derivatives as anticonvulsant agents. Bioorg. Med. Chem. Lett., 2014, 24(24), 5558-5562.
[http://dx.doi.org/10.1016/j.bmcl.2014.11.016] [PMID: 25466174]
[20]
Susanna Askanazovna, II New anticonvulsant drugs. WOPatents 1999023056A1, 1999.
[21]
Muthukrishnan Murugan, MM; Prashant Pramod, M Process for the synthesis of antiepileptic drug lacosamide. USPatents US20140012044A1, 2012.
[22]
Papo, MBY Active derivative of valproic acid for the treatment of neurological and psychotic disorders and a method for their preparation. USPatents 6323365B1, 2001.
[23]
Ashraf A-uRICSUSKMMUASN. Synthesis and biological studies of an isomeric mixture of (e/z) isoxylitones and its analogues. USPatent 20140221682A1, 2014.
[24]
Vries, OREMD Imepitoin for use in treating epileptic disorders in a feline. EPPatents3122361A1, 2015.
[25]
Bruce, E.; Maryanoff, J.F.G. Anticonvulsant sulfamate derivatives. USPatents4513006A, 1985.
[26]
Carlos, M.; Samour, JAV. Certain barbituric acid derivatives used as anticonvulsant agents. USPatents US4046894A, 1977.
[27]
Kadaba, PK 1-aryl-5-(2-oxo-1-pyrrolidinyl)-1,2,3-triazolines as novel anticonvulsants. USPatents4820721A, 1989.
[28]
Kozak, A. Phospholipid derivatives of valproic acid and mixtures thereof. USPatents20040033987A1, 2004.
[29]
Meir Bialer, BY; Kaufmann, D. Amide derivatives of valproic acid and uses thereof. USPatents8829242B2, 2014.
[30]
Xiao-Yuan, L; Janat, L. Sringer. Fructose 1,6 bisphosphate - a novel anticonvulsant drug. USPatents20100197610A1, 2010.
[31]
Pankaja, K.; Kadaba, ZL. Hydrazones, hydrazines, semicarbazones and thiosemicarbazones derived from pyridyl ketones as anticonvulsant drugs and excitatory amino acid antagonists. USPatent5942527A, 1999.
[32]
Peter, A. M.; De Witte, C.V.E.; Alexander, D. Crawford, Adriana Monserrath Orellana Paucar. Anticonvulsant activity of turmeric oil and bisabolene sesquiterpenoids. USPatent9782361B2, 2017.
[33]
Geoffrey Guy, SW Use of cannabidiol in the treatment of epilepsy. USPatents20160166514A1, 2018.
[34]
Bosmans, F. Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels. WOPatents2014120994A1, 2019.
[35]
Lees, G. Oleamide in epilepsy. WOPatents2001035939, 2002.
[36]
Dimpfel, WPD Hesperidin for the treatment of epilepsy, migraine, schizophrenia, depression and drug abuse. EPPatents1721613A1, 2007.
[37]
Klinder, TWWGK Ambroxol for treating epilepsy. EPPatents1648436A1, 2006.
[38]
Clark, C.R.; Wells, M.J.; Sansom, R.T.; Norris, G.N.; Dockens, R.C.; Ravis, W.R. Anticonvulsant activity of some 4-aminobenzamides. J. Med. Chem., 1984, 27(6), 779-782.
[http://dx.doi.org/10.1021/jm00372a013] [PMID: 6737420]
[39]
Obniska, J.; Rapacz, A.; Rybka, S.; Góra, M.; Kamiński, K.; Sałat, K.; Żmudzki, P. Synthesis, and anticonvulsant activity of new amides derived from 3-methyl- or 3-ethyl-3-methyl-2,5-dioxo-pyrrolidin-1-yl-acetic acids. Bioorg. Med. Chem., 2016, 24(8), 1598-1607.
[http://dx.doi.org/10.1016/j.bmc.2016.02.026] [PMID: 26970661]
[40]
Guan, L.P.; Zhao, D.H.; Xiu, J.H.; Sui, X.; Piao, H.R.; Quan, Z.S. Synthesis and anticonvulsant activity of N-(2-hydroxy-ethyl)amide derivatives. Arch. Pharm. (Weinheim), 2009, 342(1), 34-40.
[http://dx.doi.org/10.1002/ardp.200800153] [PMID: 19072766]
[41]
Tabatabaei Rafiei, L.S.; Asadi, M.; Hosseini, F.S.; Amanlou, A.; Biglar, M.; Amanlou, M. Synthesis and Evaluation of Anti-Epileptic Properties of New Phthalimide-4, 5-Dihydrothiazole-Amide Derivatives. Polycycl. Aromat. Compd., 2020, 1-11.
[http://dx.doi.org/10.1080/10406638.2020.1776345]
[42]
Hassan, M.Z.; Khan, S.A.; Amir, M. Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotective. Eur. J. Med. Chem., 2012, 58, 206-213.
[http://dx.doi.org/10.1016/j.ejmech.2012.10.002] [PMID: 23124217]
[43]
Armstrong, A.; Li, W.N. N′‐Carbonyldiimidazole. Encyclopedia of Reagents for Organic Synthesis, 2001.
[44]
El Kayal, W.M.; Shtrygol, S.Y.; Zalevskyi, S.V.; Shark, A.A.; Tsyvunin, V.V.; Kovalenko, S.M.; Bunyatyan, N.D.; Perekhoda, L.O.; Severina, H.I.; Georgiyants, V.A. Synthesis, in vivo and in silico anticonvulsant activity studies of new derivatives of 2-(2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)acetamide. Eur. J. Med. Chem., 2019, 180, 134-142.
[http://dx.doi.org/10.1016/j.ejmech.2019.06.085] [PMID: 31302446]
[45]
Ibrahim, M-K.; Abd-Elrahman, A.A.; Ayyad, R.R.; El-Adl, K.; Mansour, A.M.; Eissa, I.H. Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1 (2H)-yl)-N-(4-(substituted) phenyl) acetamide derivatives for biological evaluation as anticonvulsant agents. Bull. Fac. Pharm. Cairo Univ., 2013, 51(1), 101-111.
[http://dx.doi.org/10.1016/j.bfopcu.2012.11.003]
[46]
Shindikar, A.V.; Khan, F.; Viswanathan, C.L. Design, synthesis and in vivo anticonvulsant screening in mice of novel phenylacetamides. Eur. J. Med. Chem., 2006, 41(6), 786-792.
[http://dx.doi.org/10.1016/j.ejmech.2006.03.013] [PMID: 16647165]
[47]
Nath, R.; Yar, M.S.; Pathania, S.; Grover, G.; Debnath, B.; Akhtar, M.J. Synthesis and anticonvulsant evaluation of indoline derivatives of functionalized aryloxadiazole amine and benzothiazole acetamide. J. Mol. Struct., 2021, 1228, 129742.
[http://dx.doi.org/10.1016/j.molstruc.2020.129742]
[48]
Ghidini, E.; Delcanale, M.; De Fanti, R.; Rizzi, A.; Mazzuferi, M.; Rodi, D.; Simonato, M.; Lipreri, M.; Bassani, F.; Battipaglia, L.; Bergamaschi, M.; Villetti, G. Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives. Bioorg. Med. Chem., 2006, 14(10), 3263-3274.
[http://dx.doi.org/10.1016/j.bmc.2005.12.064] [PMID: 16460950]
[49]
Sudhakararao, G. Synthesis and anticonvulsant activity of certain chalcone based pyrazoline compounds. IJPR, 2015, 5(8), 179.
[50]
Singh, H.P.; Chauhan, C.; Pandeya, S.; Sharma, C.S. Chalconsemicarbazone: A new scaffold for antiepileptic drug discovery. J. Chil. Chem. Soc., 2010, 55(1), 103-106.
[http://dx.doi.org/10.4067/S0717-97072010000100024]
[51]
Bryda, J.; Zagaja, M.; Szewczyk, A.; Andres-Mach, M. Coumarins as potential supportive medication for the treatment of epilepsy. Acta Neurobiol. Exp. (Warsz.), 2019, 79(2), 126-132.
[http://dx.doi.org/10.21307/ane-2019-011] [PMID: 31342949]
[52]
Manojkumar, P.; Ravi, T.K.; Subbuchettiar, G. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells. Acta Pharm., 2009, 59(2), 159-170.
[http://dx.doi.org/10.2478/v10007-009-0018-7] [PMID: 19564141]
[53]
Amin, K.M.; Rahman, D.E.A.; Al-Eryani, Y.A. Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents. Bioorg. Med. Chem., 2008, 16(10), 5377-5388.
[http://dx.doi.org/10.1016/j.bmc.2008.04.021] [PMID: 18467106]
[54]
Siddiqui, N.; Arshad, M.F.; Khan, S.A. Synthesis of some new coumarin incorporated thiazolyl semicarbazones as anticonvulsants. Acta Pol. Pharm., 2009, 66(2), 161-167.
[PMID: 19719050]
[55]
Clark, M. Handbook of textile and industrial dyeing: Principles, processes and types of dyes; Elsevier, 2011.
[56]
Mokrov, G.; Savel’ev, V.; Voronina, T.; Litvinova, S.; Kovalev, I.; Nerobkova, L. Synthesis and Anticonvulsant Activity of N-Substituted 4-Amino-3-Nitrocoumarins. Pharm. Chem. J., 2019, 53(2), 118-124.
[http://dx.doi.org/10.1007/s11094-019-01964-7]
[57]
Diniz, TC; Silva, JC; Lima-Saraiva, SRGd; Ribeiro, FPRdA; Pacheco, AGM; de Freitas, RM The role of flavonoids on oxidative stress in epilepsy. Oxi. Med. Cell. Longev., 2015, 2015, 171756.
[58]
Kumar, N.; Chauhan, L.S. Synthesis and anticonvulsant activity of some flavones incorporated hydrazide derivatives. Int J Pharm Clin Res., 2015, 7(4), 317-322.
[59]
Parchenko, V. Anticonvulsant activity of 5-(furan-2-yl)-4R1-1, 2, 4-triazole-3-thione S-derivatives. Farm. Zh., 2015, (6), 56-60.
[http://dx.doi.org/10.32352/0367-3057.6.15.02]
[60]
Zhmurenko, L.; Litvinova, S.; Kutepova, I.; Nerobkova, L.; Mokrov, G.; Rebeko, A. Synthesis of Dibenzofuranone-Oxime Derivatives with Anticonvulsant, Antihypoxic, and Anti-Ischemic Activity. Pharm. Chem. J., 2020, 1-8.
[http://dx.doi.org/10.1007/s11094-020-02112-2]
[61]
Dawood, K.M.; Abdel-Gawad, H.; Rageb, E.A.; Ellithey, M.; Mohamed, H.A. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles. Bioorg. Med. Chem., 2006, 14(11), 3672-3680.
[http://dx.doi.org/10.1016/j.bmc.2006.01.033] [PMID: 16464601]
[62]
Sałat, K.; Filipek, B.; Więckowski, K.; Malawska, B. Analgesic activity of 3-mono-substituted derivatives of dihydrofuran-2-one in experimental rodent models of pain. Pharmacol. Rep., 2009, 61(5), 807-818.
[http://dx.doi.org/10.1016/S1734-1140(09)70136-7] [PMID: 19904003]
[63]
Więckowski, K.; Sałat, K.; Bytnar, J.; Bajda, M.; Filipek, B.; Stables, J.P.; Malawska, B. Search for anticonvulsant and analgesic active derivatives of dihydrofuran-2(3H)-one. Bioorg. Med. Chem., 2012, 20(21), 6533-6544.
[http://dx.doi.org/10.1016/j.bmc.2012.08.037] [PMID: 23010454]
[64]
Chadwick, D.; Jenner, P.; Reynolds, E.H. Amines, anticonvulsants, and epilepsy. Lancet, 1975, 1(7905), 473-476.
[http://dx.doi.org/10.1016/S0140-6736(75)92827-5] [PMID: 46954]
[65]
Apraku, J.; Okoro, C.O. Design, synthesis and anticonvulsant evaluation of fluorinated benzyl amino enaminones. Bioorg. Med. Chem., 2019, 27(1), 161-166.
[http://dx.doi.org/10.1016/j.bmc.2018.11.033] [PMID: 30503782]
[66]
Eddington, N.D.; Cox, D.S.; Khurana, M.; Salama, N.N.; Stables, J.P.; Harrison, S.J.; Negussie, A.; Taylor, R.S.; Tran, U.Q.; Moore, J.A.; Barrow, J.C.; Scott, K.R. Synthesis and anticonvulsant activity of enaminones. Part 7. Synthesis and anticonvulsant evaluation of ethyl 4-[(substituted phenyl)amino]-6-methyl-2-oxocyclohex-3-ene-1-carboxylates and their corresponding 5-methylcyclohex-2-enone derivatives. Eur. J. Med. Chem., 2003, 38(1), 49-64.
[http://dx.doi.org/10.1016/S0223-5234(02)00006-5] [PMID: 12593916]
[67]
Malik, S.; Khan, S.A. Design and synthesis of (5-amino-1, 2, 4-triazin-6-yl)(2-(benzo[d] isoxazol-3-yl) pyrrolidin-1-yl)methanone derivatives as sodium channel blocker and anticonvulsant agents. J. Enzyme Inhib. Med. Chem., 2014, 29(4), 505-516.
[http://dx.doi.org/10.3109/14756366.2013.815177] [PMID: 23914929]
[68]
Thiry, A.; Dogné, J-M.; Supuran, C.T.; Masereel, B. Anticonvulsant sulfonamides/sulfamates/sulfamides with carbonic anhydrase inhibitory activity: Drug design and mechanism of action. Curr. Pharm. Des., 2008, 14(7), 661-671.
[http://dx.doi.org/10.2174/138161208783877956] [PMID: 18336312]
[69]
Siddiqui, N.; Rana, A.; Khan, S.A.; Bhat, M.A.; Haque, S.E. Synthesis of benzothiazole semicarbazones as novel anticonvulsants--the role of hydrophobic domain. Bioorg. Med. Chem. Lett., 2007, 17(15), 4178-4182.
[http://dx.doi.org/10.1016/j.bmcl.2007.05.048] [PMID: 17572089]
[70]
Shimshoni, J.A.; Bialer, M.; Yagen, B. Synthesis and anticonvulsant activity of aromatic tetramethylcyclopropanecarboxamide derivatives. Bioorg. Med. Chem., 2008, 16(11), 6297-6305.
[http://dx.doi.org/10.1016/j.bmc.2008.03.051] [PMID: 18472270]
[71]
Ajeet, A.; Kumar, A.; Mishra, A. Design, synthesis and pharmacological evaluation of sulfonamide derivatives screened against maximal electroshock seizure test. Mol. Biol., 2018, 7(206), 2.
[72]
Farag, A.A.; Abd-Alrahman, S.N.; Ahmed, G.F.; Ammar, R.M.; Ammar, Y.A.; Abbas, S.Y. Synthesis of some azoles incorporating a sulfonamide moiety as anticonvulsant agents. Arch. Pharm. (Weinheim), 2012, 345(9), 703-712.
[http://dx.doi.org/10.1002/ardp.201200014] [PMID: 22696252]
[73]
Khokra, S.L.; Arora, K.; Khan, S.A.; Kaushik, P.; Saini, R.; Husain, A. Synthesis, computational studies and anticonvulsant activity of novel benzothiazole coupled sulfonamide derivatives. Iran. J. Pharm. Res., 2019, 18(1), 1-15.
[PMID: 31089339]
[74]
Siddiqui, N.; Arshad, M.F.; Khan, S.A.; Ahsan, W. Sulfonamide derivatives of thiazolidin-4-ones with anticonvulsant activity against two seizure models: Synthesis and pharmacological evaluation. J. Enzyme Inhib. Med. Chem., 2010, 25(4), 485-491.
[http://dx.doi.org/10.3109/14756360903282833] [PMID: 20233086]
[75]
Li, J.; Lou, J.; Wang, Z.; Wang, T.; Xiao, Y.; Hu, X.; Liu, P.; Hong, X. Design, synthesis and pharmacological evaluation of novel N-(2-(1, 1-dimethyl-5, 7-dioxo-4, 6-diazaspiro[2.4]heptan-6-yl)ethyl) sulfonamide derivatives as potential anticonvulsant agents. Eur. J. Med. Chem., 2015, 92, 370-376.
[http://dx.doi.org/10.1016/j.ejmech.2015.01.008] [PMID: 25585007]
[76]
Siddiqui, N.; Alam, M.S.; Stables, J.P. Synthesis and anticonvulsant properties of 1-(amino-N-arylmethanethio)-3-(1-substituted benzyl-2, 3-dioxoindolin-5-yl) urea derivatives. Eur. J. Med. Chem., 2011, 46(6), 2236-2242.
[http://dx.doi.org/10.1016/j.ejmech.2011.03.004] [PMID: 21435751]
[77]
He, X.; Zhong, M.; Yang, J.; Wu, Z.; Xiao, Y.; Guo, H.; Hu, X. Synthesis and anticonvulsant activity of 1-(2-(8-(benzyloxy)quinolin-2-yl)-1-butyrylcyclopropyl)-3-substituted urea derivatives. Chem. Biol. Drug Des., 2012, 79(5), 771-779.
[http://dx.doi.org/10.1111/j.1747-0285.2012.01352.x] [PMID: 22304806]
[78]
Kashaw, S.K.; Kashaw, V.; Mishra, P.; Jain, N.K.; Stables, J.P. Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl/ethyl-4H-quinazolin-3-yl)-urea. Eur. J. Med. Chem., 2009, 44(11), 4335-4343.
[http://dx.doi.org/10.1016/j.ejmech.2009.05.008] [PMID: 19674817]
[79]
Mishra, C.B.; Kumari, S.; Tiwari, M. Design and synthesis of some new 1-phenyl-3/4-[4-(aryl/heteroaryl/alkyl-piperazine1-yl)-phenyl-ureas as potent anticonvulsant and antidepressant agents. Arch. Pharm. Res., 2016, 39(5), 603-617.
[http://dx.doi.org/10.1007/s12272-016-0720-1] [PMID: 26891908]
[80]
Prakash, C.R.; Raja, S. Design, synthesis and antiepileptic properties of novel 1-(substituted benzylidene)-3-(1-(morpholino/piperidino methyl)-2,3-dioxoindolin-5-yl)urea derivatives. Eur. J. Med. Chem., 2011, 46(12), 6057-6065.
[http://dx.doi.org/10.1016/j.ejmech.2011.10.020] [PMID: 22037252]
[81]
Mohammed Faiz Arshad, F.A-O.; Mustafa, G.; Shousha, S.; Alshahrani, A.R. β-Naphthalene Incorporated Thiazole-5-Carboxamides/Thiazole -5- Ketones: Design, Synthesis and Anticonvulsant Screening against Two Seizure Models. Am. J. Pharmacol. Toxicol., 2019, 14, 27-37.
[http://dx.doi.org/10.3844/ajptsp.2019.27.37]
[82]
Azam, F.; El-Gnidi, B.A.; Alkskas, I.A. Combating oxidative stress in epilepsy: Design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides. Eur. J. Med. Chem., 2010, 45(7), 2817-2826.
[http://dx.doi.org/10.1016/j.ejmech.2010.02.063] [PMID: 20356656]
[83]
Ghareb, N.; Abdel Daim, M.M.; El-Sayed, N.M.; Elgawish, M.S. Synthesis, molecular modelling, and preliminary anticonvulsant activity evaluation of novel naphthalen-2-yl acetate and 1,6-dithia-4,9-diazaspiro [4.4] nonane-3,8-dione derivatives. Bioorg. Chem., 2017, 71, 110-119.
[http://dx.doi.org/10.1016/j.bioorg.2017.01.018] [PMID: 28162233]
[84]
Gasior, M.; Carter, R.B.; Goldberg, S.R.; Witkin, J.M. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam. J. Pharmacol. Exp. Ther., 1997, 282(2), 543-553.
[PMID: 9262314]
[85]
Reddy, D.S. Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy. Front. Endocrinol. (Lausanne), 2011, 2, 38.
[http://dx.doi.org/10.3389/fendo.2011.00038] [PMID: 22654805]
[86]
Upasani, R.B.; Yang, K.C.; Acosta-Burruel, M.; Konkoy, C.S.; McLellan, J.A.; Woodward, R.M.; Lan, N.C.; Carter, R.B.; Hawkinson, J.E. 3 α-Hydroxy-3 β-(phenylethynyl)-5 β-pregnan-20-ones: Synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors. J. Med. Chem., 1997, 40(1), 73-84.
[http://dx.doi.org/10.1021/jm9605344] [PMID: 9016330]
[87]
Runyon, S.P.; Orr, M.; Navarro, H.A.; Kepler, J.A.; Rogawski, M.A.; Kaminski, R.M.; Cook, C.E. 17β-Nitro-5α-androstan-3α-ol and its 3β-methyl derivative: Neurosteroid analogs with potent anticonvulsant and anxiolytic activities. Eur. J. Pharmacol., 2009, 617(1-3), 68-73.
[http://dx.doi.org/10.1016/j.ejphar.2009.06.052] [PMID: 19577558]
[88]
Kulandasamy, R.; Adhikari, A.V.; Stables, J.P. A new class of anticonvulsants possessing 6 Hz activity: 3,4-dialkyloxy thiophene bishydrazones. Eur. J. Med. Chem., 2009, 44(11), 4376-4384.
[http://dx.doi.org/10.1016/j.ejmech.2009.05.026] [PMID: 19556038]
[89]
Góra, M.; Czopek, A.; Rapacz, A.; Dziubina, A.; Głuch-Lutwin, M.; Mordyl, B.; Obniska, J. Synthesis, Anticonvulsant and Antinociceptive Activity of New Hybrid Compounds: Derivatives of 3-(3-Methylthiophen-2-yl)-pyrrolidine-2,5-dione. Int. J. Mol. Sci., 2020, 21(16), 5750.
[http://dx.doi.org/10.3390/ijms21165750] [PMID: 32796594]
[90]
El-Sharkawy, K.; El-Sayed, N.; Zaki, M. Uses of 2-Amino-5, 6-dihydro-4H-cyclopenta [b] thiophene-3-carbonitrile in the Synthesis of Heterocyclic Compounds with Anticonvulsant, Behavioral and CNS Antidepressant Activities. Int. Res. J. Pure Appl. Chem., 2012, 91-104.
[http://dx.doi.org/10.9734/IRJPAC/2012/1222]
[91]
Ahmad, G.; Rasool, N.; Rizwan, K.; Imran, I.; Zahoor, A.F.; Zubair, M.; Sadiq, A.; Rashid, U. Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl)thiophene-2-carboxamide analogs. Bioorg. Chem., 2019, 92, 103216.
[http://dx.doi.org/10.1016/j.bioorg.2019.103216] [PMID: 31491567]
[92]
Amr, A-GE; Hegab, MI; Ibrahiem, AA; Abdulla, MM Synthesis and reactions of some fused oxazinone, pyrimidinone, thiopyrimidinone, and triazinone derivatives with a thiophene ring as analgesic, anticonvulsant, and antiparkinsonian agents. Monatshefte für Chemie/Chemical Monthly, 2003, 134(10), 1395-1409.
[http://dx.doi.org/10.1007/s00706-003-0051-z]
[93]
Kulandasamy, R.; Adhikari, A.V.; Stables, J.P. Synthesis and anticonvulsant activity of some new bishydrazones derived from 3,4-dipropyloxythiophene. Eur. J. Med. Chem., 2009, 44(9), 3672-3679.
[http://dx.doi.org/10.1016/j.ejmech.2009.02.009] [PMID: 19286282]
[94]
Jawed Ahsan, M. Semicarbazone analogs as anticonvulsant agents: A review. Cent. Nerv. Syst. Agents Med. Chem., 2013, 13(2), 148-158.
[95]
Kamal, M.; Jawaid, T. A Systematic Review of Semicarbazones as an Anticonvulsant Agent. Am J Pharm Tech Res., 2013, 3(5), 162-184.
[96]
Alam, O.; Mullick, P.; Verma, S.P.; Gilani, S.J.; Khan, S.A.; Siddiqui, N.; Ahsan, W. Synthesis, anticonvulsant and toxicity screening of newer pyrimidine semicarbazone derivatives. Eur. J. Med. Chem., 2010, 45(6), 2467-2472.
[http://dx.doi.org/10.1016/j.ejmech.2010.02.031] [PMID: 20211511]
[97]
Yogeeswari, P.; Thirumurugan, R.; Kavya, R.; Samuel, J.S.; Stables, J.; Sriram, D. 3-Chloro-2-methylphenyl-substituted semicarbazones: Synthesis and anticonvulsant activity. Eur. J. Med. Chem., 2004, 39(8), 729-734.
[http://dx.doi.org/10.1016/j.ejmech.2004.03.008] [PMID: 15276306]
[98]
Yogeeswari, P.; Sriram, D.; Veena, V.; Kavya, R.; Rakhra, K.; Ragavendran, J.V.; Mehta, S.; Thirumurugan, R.; Stables, J.P. Synthesis of aryl semicarbazones as potential anticonvulsant agents. Biomed. Pharmacother., 2005, 59(1-2), 51-55.
[http://dx.doi.org/10.1016/j.biopha.2004.04.013] [PMID: 15740936]
[99]
Yogeeswari, P.; Sriram, D.; Mehta, S.; Nigam, D.; Kumar, M.M.; Murugesan, S.; Stables, J.P. Anticonvulsant and neurotoxicity evaluation of some 6-substituted benzothiazolyl-2-thiosemicarbazones. Farmaco, 2005, 60(1), 1-5.
[http://dx.doi.org/10.1016/j.farmac.2004.09.001] [PMID: 15652361]
[100]
Dimmock, J.; Pandeya, S.; Quail, J.; Pugazhenthi, U.; Allen, T.; Kao, G. Evaluation of the semicarbazones, thiosemicarbazones and bis-carbohydrazones of some aryl alicycylic ketones for anticonvulsant and other biological propertie. Eur. J. Med. Chem., 1995, 30(4), 303-314.
[http://dx.doi.org/10.1016/0223-5234(96)88238-9]
[101]
Rastogi, S; Rastogi, H An efficient synthesis of some substituted piperidin-4-one thiosemicarbazone derivatives as potential anticonvulsant under microwave irradiation. Indian J. Chem., 2010, 49, 547-553.
[http://dx.doi.org/10.1002/chin.201038154]
[102]
Divar, M.; Yeganeh, Y.; Jamshidzadeh, A.; Heidari, R.; Khabnadideh, S. Anticonvulsant activity of some semicarbazone and thiosemicarbazone derivatives of isatin on PTZ induced seizure. JIAPS, 2017, 2(3), 4-14.
[103]
Nevagi, R.J.; Dhake, A.S.; Narkhede, H.I.; Kaur, P. Design, synthesis and biological evaluation of novel thiosemicarbazide analogues as potent anticonvulsant agents. Bioorg. Chem., 2014, 54, 68-72.
[http://dx.doi.org/10.1016/j.bioorg.2014.04.002] [PMID: 24821317]
[104]
Yogeeswari, P.; Sriram, D.; Sunil, J.L.R.; Kumar, S.S.; Stables, J.P. Anticonvulsant and neurotoxicity evaluation of some 6-chlorobenzothiazolyl-2-thiosemicarbazones. Eur. J. Med. Chem., 2002, 37(3), 231-236.
[http://dx.doi.org/10.1016/S0223-5234(02)01338-7] [PMID: 11900867]
[105]
Dong, S.; Wang, T.; Hu, C.; Chen, X.; Jin, Y.; Wang, Z. Design and Synthesis of 5-Substituted Benzo[d][1,3]dioxole Derivatives as Potent Anticonvulsant Agents. Arch. Pharm. (Weinheim), 2017, 350(2), 1600274.
[http://dx.doi.org/10.1002/ardp.201600274] [PMID: 28092111]
[106]
Calderon, S.N.; Newman, A.H.; Tortella, F.C. Novel 1-phenylcycloalkanecarboxylic acid derivatives as potential anticonvulsant agents. J. Med. Chem., 1991, 34(11), 3159-3164.
[http://dx.doi.org/10.1021/jm00115a002] [PMID: 1956032]

Rights & Permissions Print Cite
Article Metrics
20
1
© 2024 Bentham Science Publishers | Privacy Policy